Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Van Bockstaele, Elisabeth J. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2013.
Edición:1st ed. 2013.
Materias:
LEADER 02376nam a22003375i 4500
001 000283667
005 20210513105337.0
007 cr nn 008mamaa
008 130707s2013 xxu| s |||| 0|eng d
020 |a 9781461479406 
024 7 |a 10.1007/978-1-4614-7940-6  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders /  |c edited by Elisabeth J. Van Bockstaele. 
250 |a 1st ed. 2013. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2013. 
300 |a IX, 337 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Endocannabinoids and monoamines: modulating the modulators -- Endocannabinoid-mediated synaptic plasticity -- Current cannabinoid receptor nomenclature and pharmacological principles -- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction -- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders -- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers -- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion -- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function -- Endocannabinoids, Monoamines and Stress -- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders -- Endocannabinoid Signaling and the Regulation of the Serotonin System -- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors -- Involvement of serotonergic system in cannabinoid analgesia -- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis. 
650 0 |a Neurosciences. 
650 0 |a Neurology . 
650 0 |a Psychiatry. 
650 0 |a Neurochemistry. 
650 1 4 |a Neurosciences. 
650 2 4 |a Neurology. 
650 2 4 |a Psychiatry. 
650 2 4 |a Neurochemistry. 
700 1 |a Van Bockstaele, Elisabeth J.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks